Skip to content
Lower risk Drug recall · FDA · Published July 11, 2024

Healthy Living Acetaminophen Tablets Recall: Missing Manufacturer Label

Aurobindo Pharma recalls 100-count Healthy Living Acetaminophen, Aspirin and Caffeine tablets due to missing manufacturer label. This affects some bottles sold in the US with specific lot numbers.

🇺🇸 FDA recall #D-0641-2024DrugAurobindo Pharma ›
Take action

Contact the company

Recalling firmAurobindo Pharma USA Inc279 Princeton Hightstown Rd · East Windsor, NJ 08520-1401
✎ GovInfoNow plain-language explainer

Aurobindo Pharma is recalling 100-count Healthy Living Acetaminophen, Aspirin and Caffeine tablets because some bottles lack the required manufacturer label. This recall is important because the missing label makes it difficult to verify the product's contents and safety. Read more at govinfonow.com/recall/32589-healthy-living-acetaminophen-tablets-recall-missing-manufacturer-label.

Source Summary by GovInfoNow · govinfonow.com/recall/32589-healthy-living-acetaminophen-tablets-recall-missing-manufacturer-label · Updated September 23, 2026 · FDA enforcement record: FDA #D-0641-2024

Cite this page

“Healthy Living Acetaminophen Tablets Recall: Missing Manufacturer Label.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/32589-healthy-living-acetaminophen-tablets-recall-missing-manufacturer-label. Based on FDA recall #D-0641-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0641-2024%22&limit=1).

Aurobindo Pharma USA Inc recalled Healthy Living Acetaminophen, Aspirin (NSAID) and Caffeine tablets due to missing manufacturer labels that include drug facts information, the FDA said on July 11, 2024. The recall affects 240 bottles distributed in New Jersey, New York and Pennsylvania.

How to tell if you have it

  • Brand: Healthy Living
  • Product: Acetaminophen, Aspirin (NSAID) and Caffeine, tablets USP, 250 mg/250 mg/65 mg
  • Packaging: 100-count bottles
  • Lot code: AC2523005A
  • Expiration date: 6/30/2025
  • NDC: 58602-882-21
  • Quantity: 240 bottles
  • Distribution: NJ, NY & PA

The hazard

Some bottles are missing the manufacturer's label that includes the drug facts information. The FDA has classified this recall as Class I.

Context

GovInfoNow's records show Aurobindo Pharma USA Inc has 32 other recalls on record since April 9, 2013. Other recent recalls of similar products include American Regent Levocarnitine Injection Recall: Missing Label Hazard (April 16, 2026), Aero Healthcare Acetaminophen Caffeine Capsules: Label Mix-Up in Outer Box (Oct. 17, 2025) and Ascend Laboratories recalls Amlodipine/Olmesartan tablets with low drug content (July 8, 2026). FDA's FAERS adverse-event database contains 115 adverse-event reports naming this product, all years, 95 of them marked serious and 26 listing a death.

How to tell if you have this one

Check for the label with the manufacturer information on the bottle. The recalled product has the lot number AC2523005A and was distributed by Aurohealth LLC in the US.

  • Brand
    Aurobindo Pharma
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Label

    Look for the manufacturer label that includes drug facts information on the bottle.

Where it went and when

Where it was distributed

Distributed in 3 states.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: yesNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: yesPANew Jersey: yesNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “NJ, NY & PA” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: New Jersey, New York, Pennsylvania.

Recall timeline

FDA published this recall 48 days after the firm started it.

1. Firm started the recall: Jul 11, 202412. FDA classified it Class I: Aug 20, 202423. Published in FDA’s Enforcement Report: Aug 28, 202432024
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Aurobindo Pharma recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0641-2024 (July 11, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0641-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA